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Abstract 
Posterior Capsular Opacification (PCO) is the capsule fibrosis developed on implanted 
IntraOcular Lens (IOL) by the de-differentiation of Lens Epithelial Cells (LECs) undergoing 
Epithelial Mesenchymal Transition (EMT). Literature has shown that the incidence of PCO is 
multifactorial including the patient’s age or disease, surgical technique, and IOL design and 
material. Reports comparing hydrophilic and hydrophobic acrylic IOLs have shown that the 
former has more severe PCO. On the other hand, we have previously demonstrated that the 
adhesion of LECs is favored on hydrophobic compared to hydrophilic materials. By combining 
these two facts and contemporary knowledge in PCO development via the EMT pathway, we 
propose a biomimetically inspired strategy to promote LEC adhesion without de-differentiation to 
reduce the risk of PCO development. By surface grafting of a cell adhesion molecule (RGD 
peptide) onto the conventional hydrophilic acrylic IOL material, the surface-functionalized IOL 
can be used to reconstitute a capsule-LEC-IOL sandwich structure, which has been considered to 
prevent PCO formation in literature. Our results show that the innovative biomaterial improves 
LEC adhesion, while also exhibiting similar optical (light transmittance, optical bench) and 
mechanical (haptic compression force, IOL injection force) properties compared to the starting 
material. In addition, compared to the hydrophobic IOL material, our bioactive biomaterial 
exhibits similar abilities in LEC adhesion, morphology maintenance, and EMT biomarker 
expression, which is the crucial pathway to induce PCO. The in vitro assays suggest that this 
biomaterial has the potential to reduce the risk factor of PCO development. 
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Introduction 
Cataract is the opacity of the crystalline lens or capsule of the eye, causing impairment 
of vision or even blindness. Cataract surgery, with damaged native lens extraction and 
IntraOcular Lens (IOL) implantation, is still the only currently available treatment. 
Nowadays, the conventional materials used for IOLs include PMMA (Poly(Methyl 
MethAcrylate)), silicone, hydrophobic acrylic, and hydrophilic acrylic polymers [1-5]. 
Secondary cataract, or Posterior Capsular Opacification (PCO), is the most common 
postoperative complication of cataract surgery. PCO involves the clouding of the 
posterior capsule by the lens epithelial cells (LECs), forming a thick layer on the IOL and 
causing loss of vision again. Although Nd:YAG laser capsulotomy has been used to treat 
PCO by creating a hole in the clouded lens capsule to allow light to pass to the retina. 
This method also potentially creates other complications such as damage to the IOL, 
higher intraocular pressure, cystoid macular edema, and retinal detachment [1,6]. The 
problem of PCO has been a challenge to scientists and ophthalmologists for decades. 
The biological basis of PCO has been investigated [7]. In the normal crystalline lens, the 
LECs attach to the anterior capsule and form a monolayer. The LECs are quiescent in a 
contact-inhibition status. During cataract surgery, the structure is broken and the 
residual LECs become active in proliferation and migrate into the space between the 
posterior capsule and the IOL. The LECs further undergo Epithelial-Mesenchymal 
Transition (EMT) and transdifferentiate to fibroblasts. These cells express α-smooth 
muscle actin and secrete collagen I, III, V, and VI, which are not normally present in the 
lens. The extracellular matrix network and the over-proliferated cells scatter light and 
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lead to PCO. Another concept of tissue response to biomaterials has also been 
suggested to explain PCO formation [8]. Surgical trauma provokes the breakdown of 
blood–aqueous barrier (BAB) and the infiltration of macrophages and giant cells, further 
inducing foreign body reactions. These cells secrete cytokines including transforming 
growth factor β (TGF-β), and ﬁbroblast growth factors (FGFs) which promote EMT and 
fibroblast transdifferentiation. At the final stage, the fibrous encapsulation of IOLs 
marks the end of tissue self-healing and the formation of PCO [7,9]. 
PCO is known to be multifactorial. The incidence can be inﬂuenced by the patient’s age 
or disease, surgical technique, and IOL design and material [10]. Research scientists and 
ophthalmologists worldwide have attempted to alleviate PCO development. These 
attempts can be categorized into the improvement of surgical techniques, the use of 
therapeutic agents, IOL materials and designs, and combination therapy [6].  
The improvement in the surgical technique is mainly focused on the removal of LECs at 
the time of lens extraction. The proposed techniques, including aspirating/polishing 
anterior or posterior capsule, have been reported to delay but not to eliminate PCO for 
the reason that PCO is mainly caused by germinative LECs in the equatorial region rather 
than the displaced metaplastic LECs already on the posterior capsule [6]. 
Hydrodissection, injection of physiological saline fluid stream in-between the capsular 
bag and lens to facilitate the removal of retained cortical material and LECs, was shown 
to be important for PCO prevention [11]. However, it does not completely eliminate 
LECs. 
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The research of therapeutic agents is mainly focused on selectively destroying residual 
LECs without causing toxic effects to other intraocular tissues. The routes of 
administration can be direct injection into the anterior chamber, addition to the 
irrigating solution, impregnation of the IOL, or iontophoresis [12]. Unfortunately, a wide 
range of pharmacological agents as well as cytotoxic and therapeutic agents have shown 
the potential to prevent PCO in vitro, but exhibit toxic effects to the nearby ocular 
tissues in vivo [6]. The lack of selectivity currently limits their clinical use. 
Scientists are also devoted to reducing PCO by developing IOL materials and designs. 
PCO was regarded as an inevitable consequence of lens implant surgery until 1993, 
when the clinical trial of the hydrophobic acrylic IOL (Acrysof IOL MA series, Alcon 
Laboratories) was conducted [10]. In 2000, Nishi and his colleagues proposed a method 
of  preventing PCO development by square-edge IOL design, which involved the sharp-
edge of IOL inhibiting cell migration to the optic part along the lens capsule [13]. The 
square-edge IOL was later improved with 360° design to prevent cell migration via 
haptic-optic junction and achieved a significant decrease in PCO formation [14-16]. 
However, more and more evidences are showing that the square-edge design can only 
delay rather than prevent PCO formation [17-19]. Recently, adhesion-preventing ring 
designs have been proposed to inhibit PCO by separating the anterior and posterior 
capsular ﬂaps which allow aqueous humor to circulate in and out of the capsular bag 
and lead to LEC proliferation inhibition [20,21]. However, the biological mechanism of 
these designs in PCO inhibition is yet to be investigated [22]. Nowadays, it is generally 
accepted that the square-edge design and hydrophobic acrylic material are better 
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choices to inhibit PCO. PCO is, however, still a challenge to scientists and 
ophthalmologists. 
The materials for IOLs require excellent optical properties for light transmission, 
mechanical properties for folding injection during surgery, and biological properties for 
preventing unfavored body reaction. Biocompatibility is generally accepted as the ability 
of biomaterials or medical devices to perform specific functions with appropriate host 
response [9]. For IOLs, the biocompatibility can be assessed in terms of uveal and 
capsular compatibility, which are the inﬂammatory foreign-body reaction of the eye 
against the implant and the relationship of the IOL with remaining LECs within the 
capsular bag, respectively [23]. Among the acrylic materials, the hydrophilic ones are 
superior to the hydrophobic ones in the uveal aspect, which is inversely related to 
inflammation [24]. However, the hydrophilic acrylic material is considered less capsular 
biocompatible, which is related to the higher incidence of PCO [25].  
The molecular basis of high PCO incidences in hydrophilic IOL materials has been 
speculated by protein adsorption behaviors [26,27]. Linnola et al. have shown that more 
fibronectin was adsorbed on the hydrophobic IOLs than on the hydrophilic ones [28-30]. 
Therefore, the hydrophobic IOL can be considered as bio-sticky (i.e. stick to the capsular 
bag via the adsorbed proteins or via the adsorbed adhesion protein-induced cell layer 
mechanism) [31]. This glue effect could possibly inhibit the migration of residual LECs 
tending to invade the posterior capsule from the haptic–optic junction [19,32]. On the 
other hand, in the in vitro culture experiments, LEC differentiation is drastically 
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accelerated if the cells are not well attached [33]. In this context, Linnola also proposed 
a “Sandwich Theory” model to control PCO [34]. In this model, a sandwich-like structure 
of fixed LECs between the lens capsular bag and IOL could be formed by selecting a 
sticky IOL material. The LECs regained the mitotically quiescent status and diminished 
eventually without provoking PCO. 
The hydrophilic acrylic polymer, mainly composed by pHEMA (Poly(2-HydroxyEthyl 
MethAcrylate)), has several superior characteristics. Surgeons benefit from its foldability 
and controlled unfolding behavior. Patients suffer less from glistening and the glare 
phenomenon [1]. For the manufacturers, the rigidity in the dry state is helpful for easy 
machining. However, IOLs made from this material are prone to induce secondary 
cataract [32]. Therefore, it will be beneficial to improve the capsular biocompatibility of 
hydrophilic acrylic materials. With the hypothesis of “Sandwich Theory”, we assume 
that the ability to attract LEC adhesion is one of the key factors in PCO development.   
Our strategy of PCO control is to improve the hydrophilic IOL capsular biocompatibility 
by creating a higher LEC affinity surface. We recently highlighted their particular 
properties in terms of adhesion forces, LECs adhesion, and tissue response as indicators 
of PCO development risk [27]. In this study, we propose a strategy to reduce the risk 
factor of PCO by functionalizing the surface of hydrophilic acrylic reticulated polymer of 
25% water content (HA25) with a cell adhesion peptide containing the Arg-Gly-Asp 
sequence (RGD peptides [35]), and we characterized these surfaces using X-ray 
photoelectron spectroscopy and contact angle measurements. To evaluate the PCO 
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control performance, in vitro LEC culture was performed and compared to a 
hydrophobic acrylic material (Glistening-Free polymer, GF) considered here as a 
negative PCO control. Additionally, in order to ensure that the surface functionalization 
process does not compromise the material properties, optical and mechanical 
properties of functionalized polymers were conducted and compared with control 
materials. 
 
Materials and methods 
Cross-linked hydrophilic acrylic polymer of water uptake 25% (HA25) was obtained from 
Benz Research and Development (BRD, Sarasota, USA), and the cross-linked 
hydrophobic acrylic polymer of Glistening-Free (WO 2006/063994) was obtained from 
PhysIOL (Liège Science Park, Liège, Belgium). Disks were diamond-turned and milled 
down to a thickness of 1 mm and a diameter of 14.5 mm and were then treated 
according to procedures typically applied for IOL manufacturing. The HA25-based IOLs 
were obtained from PhysIOL. The chemical structure of virgin HA25 is shown in Fig. 1. 
KRGDSPC peptide (denoted as RGD), its negative control KRGESPC peptide (an analog of 
the RGD peptide without integrin-interacting function, denoted as RGE), and 
fluorescein-labeled KRGDSPC peptide (denoted as FITC-RGD) were purchased from 
Genecust (Luxembourg). The chemical structure of the peptides are shown in Fig. 2. 
Primary antibodies including mouse anti-α-SMA (ab7817), rat anti-tubulin (ab6160), and 
mouse anti-cytokeratin (ab668) were purchased from Abcam (Cambridge, UK). 
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Fluorescent secondary antibodies Alexa Fluor 594 goat anti-mouse (A-11032) and Alexa 
Fluor 488 chicken anti-rat (A-21470) were purchased from Life Technology (Gent, 
Belgium). Porcine TGF-β1 (101-B1-001) was purchased from R&D systems (Minneapolis, 
USA) and rapamycin was purchased from Apollo Scientific (UK). The peptide-
functionalized surface and its controls are listed in Table 1. 
  
Peptide grafting 
The schematic illustration of the peptide grafting procedure is shown in Fig. 3. IOL 
samples made by HA25 were specifically used in optical (optical bench measurement) 
and mechanical (haptic compression force, IOL injection force) properties analysis. Disk 
samples made by HA25 were used as models for all the other tests. The disk and IOL 
samples were rinsed with deionized water before overnight air drying. Dried samples 
were then placed into the chamber of radio frequency glow discharge (RFGD) 
instrument (customized, Europlasma).  Surface activation by plasma treatment was 
driven at 200 W for 10 minutes. The flow rate of oxygen gas was set at 15 Sccm, and the 
system pressure was maintained at 50 mTorr. After plasma treatment, the samples 
were immersed into the coupling solution containing 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) 150 mM, N-hydroxysuccinimide (NHS) 100 
mM, and 2-(N-morpholino)ethanesulfonate (MES) 100 mM at 4°C overnight. After 
rinsing with MilliQ water, the samples were conjugated with peptides by incubation 
with 1 mM peptide solution for 24 hours at room temperature.  
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To remove the physically adsorbed peptides, the samples were extracted in deionized 
water combined with ultrasonication (ultrasonic cleaning) and elevated temperature 
(autoclave). The samples after peptide solution incubation were placed in a MilliQ 
water-filled chamber of ultrasonication (35 kHz, 60 W, Elmasonic One, Germany) for 1 
hour. Then each sample was placed in a glass container filled with MilliQ water and 
subjected to autoclave (120°C, 1 bar) for 45 minutes. The autoclave treatment was 
performed for 10 cycles with fresh MilliQ water every time.  
For the control samples (Fig. S1), peptide adsorption effect controls (RGD ads, FITC-RGD 
ads, and RGE ads) were made by direct incubation of virgin dried HA25 material with the 
same peptide solution followed by the same washing steps as mentioned above. Plasma 
effect control (HA25 plasma) was prepared only by the plasma and immersed in MilliQ 
water immediately after the treatment. 
 
X-ray photoelectron spectroscopy (XPS) characterization 
A ThermoFisher Scientific K-ALPHA spectrometer was used for disk surface analysis with 
a monochromatized AlKα source (hν=1486.6 eV) and a 200 micron spot size. A pressure 
of 10-7 Pa was maintained in the chamber during analysis. The full spectra (0-1150eV) 
were obtained at a constant pass energy of 200eV and high resolution spectra at a 
constant pass energy of 40 eV. Charge neutralization was required for all insulating 
samples. High resolution spectra were fitted and quantified using the AVANTAGE 
software provided by ThermoFisher Scientific. 
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Cell culture 
Lens epithelial cells (LECs) were isolated from the lens crystalline anterior capsular bag 
of pig eyes (Pietrain-Landrace pig; from Detry SA. Aubel, Belgium) as previously 
described [36]. The complete culture medium was composed of 85% Dulbecco’s 
Modified Eagle’s Medium (BE12-733, Lonza), 10% fetal bovine serum (10270-106, Gibco), 
1% penicillin/streptomycin antibiotics (BE17-602, Lonza), 1% non-essential amino acids 
(NEAA) (BE13-114, Lonza), 1% sodium pyruvate (BE 13-115, Lonza), 1% Glutamax (35050 
Gibco, Invitrogen, Oregon, United States), and 1% HEPES (17-737, Lonza, Vervier, 
Belgium). The cells were cultured in an incubator under the condition of 5% CO2 
enriched atmosphere at 37°C. Trypsin-EDTA (Gibco, Invitrogen) was used for cell 
detachment after one rinse with PBS without calcium and magnesium (BE17-516, Lonza). 
 
Cell adhesion assay 
The cell adhesion assay on polymer disks was previously described elsewhere [27]. The 
peptide-immobilized (i.e. grafted and adsorbed) polymer disk samples were cut into 14 
mm diameter disks, washed and sterilized in PBS (with Ca2+ and Mg2+) (BE17-513, Lonza) 
at 1 bar, 120 °C, for 21 minutes. The polytetrafluoroethylene (PFTE) cell culture (SIRRIS 
customized, Liège, Belgium) inserts with an inner diameter of 12 mm were also sterilized 
by autoclave. Each disk was put into a well of a 12-well culture plate (from Greiner Bio-
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One, Frickenhausen, Germany) and fixed by an insert for cell seeding. The LEC 
concentration was adjusted to 1.59x105 cells/mL. For each well, 750 μL of cell 
suspension was added (1.4x105 cells/cm2). The cells were seeded on surfaces without 
serum for 6 hours to allow the RGD peptides to act on receptors without the hassle of 
serum proteins. The unattached cells and the serum-free culture medium were removed 
after 6 hours of serum-free incubation. The remaining attached cells were further 
cultured in fresh complete medium for 3 days to allow cell spreading and proliferation. 
In order to evaluate the LEC adhesion, the cell culture was stopped for further 
immunofluorescence staining. The culture medium was removed, and the samples were 
carefully washed with PBS (with Ca2+ and Mg2+) in order to eliminate the non-adhering 
and dead cells.  
EMT can be indicated by cell shape [37] and spatial distribution [38]. Epithelial cells are 
rounded/polygonal in shape and organized in clusters whereas mesenchymal cells are 
elongated/flattened in shape and scattered. However, if the cultured cells are close to 
confluence, the cells can adapt a distinct growth form and acquire overlapping 
cytoplasmic expansions. Therefore, for the EMT induction or inhibition by porcine TGF-β 
or rapamycin, the cell preparation and complete DMEM medium were the same as 
mentioned above. The conditions of porcine TGF-β 20 ng/µL and rapamycin 20 nM were 
tested by addition of each component into the TCPS culture flask. Moreover, in order to 
better observe the shape and spatial distribution of individual cells, the cells were 
cultured for 1 day rather than 3 days to avoid confluence. 
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Immunofluorescence of EMT markers 
The cell fixation step was performed with 4% paraformaldehyde in PBS at room 
temperature for 20 minutes. Cell permeabilization was performed with 0.5% Triton X-
100 in PBS at 4°C for 20 minutes. Blocking was performed with 1% BSA in PBS at 37°C for 
1 hour. Primary antibody incubation was performed in 0.05% Tween-20 in PBS solution 
with corresponding dilutions (1:100 for αSMA, 1:1000 for tubulin, and 1:200 for 
cytokeratin) at 37°C for 1 hour. Secondary antibody incubation was performed in 0.05% 
Tween-20 in PBS solution with a dilution of 1:200 at 37°C for 1 hour. The stained sample 
surface was observed with an IX81 optical inverted microscope equipped with a UPlanFL 
objective at x10 magnification  with an XCite-iris IX fluorescence unit and a C-BUN-F-
XC50 charge-coupled-device camera (Olympus Optical Co., Ltd). The size of each image 
was 625 µm x 930 µm. The full image area corresponded to 581,250 µm2 (10,036,224 
pixels) and was related to a cell coverage of 100%. At least three images per condition 
were acquired. For quantification of attached LECs on the surfaces, we used the image 
analysis software “CellSens” (Olympus). Threshold values were determined empirically 
by selecting a setting, which appeared similar to the original photomicrograph but with 
minimal background. After threshold selection, the resulting image was then converted 
to a binary image and the coverage % was reported by the software automatically. The 
colored merged images were generated by the channels combining function of the same 
software.  
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Optical properties 
The light transmittance test on disks was accomplished by keeping the samples 
hydrated and placing them onto a plastic 96-well plate for optical density scanning. 
Spectrum scan was set from 200 nm to 999 nm with 1 nm interval (PowerWave, BioTek). 
The absorbance was obtained and transformed to light transmittance after blank 
subtraction. The spectra were recorded from 370 nm to 999 nm. 
The optical bench measurement protocol was described previously [39] and aims at 
verifying the preservation of the optical performance of the IOL after modification. The 
protocol consists of conditioning the neat and modified IOLs in physiological solution 
(0.9% NaCl, Baxter) for at least 24 hours, and analyzing with an optic bench (NIMO 
TR0815, Lambda X) their optical properties (optical power and contrast sensitivity, 
expressed by the modulation transfer function (MTF)). This test was performed 
according to ISO 11979-2. The IOLs (1 per IOL model) were positioned in a quartz 
cuvette filled with physiological solution (0.9% NaCl, Baxter). The measurement was 
performed at a 3.0 mm aperture and a spatial frequency of 100 cycles/mm. 
 
Mechanical properties 
The mechanical tests on IOLs comprised evaluation of the lens foldability upon injection 
and the capacity of the lens haptics to support lens stabilization at different capsular bag 
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sizes. They were designed and performed according to ISO 11979-3 and the detailed 
protocols were described previously [39].   
Briefly, the IOL injectability was tested with the injection system Accuject 2.2 -1P 
(Medicel AG) at 21°C with a compression/traction mechanical bench (FL Plus Lloyd 
Instruments, Ametek) with a possible value variation of less than 0.05%, simulating 
surgical manipulation. The test equipment was supplied with a load cell of 100 N and 
operated with Nexygen FM software (Chatillon, Ametek, Inc.). The force applied by the 
haptics to the capsular bag (for simulated capsular bag size of 11.0 mm, 10.5 mm, 10.0 
mm, and 9.5 mm) was estimated by a compression force tester (MFC-1385-IOL, Applied 
Micro Circuits Corp.). The possible value variation is smaller than 0.2%. 
 
Contact angle measurement 
Before the measurement, the sample disks were rinsed in MilliQ water and then dried in 
an oven at 35°C for 2 days. The aqueous contact angle was measured (4 measurements/ 
water droplet, 2 droplets/ disk, 3 disks/ sample) with a dual-gradient density contact 
angle meter (DGD Fast/60) coupled to WindropCC software (Digidrop, GBX). The static 
contact angles were measured by the water-droplet method after deposition of 15 µL 
deionized water on the dry disk surfaces. 
 
L929 cell viability test with conditioned media (MTS Assay) 
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Each conditioned medium was prepared by immersing a 14.5 mm polymer disk into 1.2 
mL of complete culture medium (87% Dulbecco’s Modified Eagle’s Medium (BE12-733, 
Lonza), 10% fetal bovine serum (10270-106, Gibco), 1% penicillin/streptomycin 
antibiotics (BE17-602, Lonza), 1% sodium pyruvate (BE13-115, Lonza), and 1% Glutamax 
(35050, Gibco)) in a 12-well culture plate and incubated at 37°C, 5% CO2 for 3 days. 
These conditioned media were added to wells containing adherent mouse L929 cells. 
Mouse L929 cells were precultured in a 96-well culture plate. The seeding amount for 
each well was 2000 cells in 100 μL of culture medium. After one day in culture, the 
medium was removed and the wells were replenished with 100 µL of disk-conditioned 
medium or unconditioned fresh medium as controls (100 % viability). The cells were 
cultured for another 3 days. The medium was then replaced by fresh DMEM/F-12 
(21041-025, Gibco) and an additional 20 μL of MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) solution (G5421, Promega) 
was added. The MTS compound was bio-reduced by cells into a colored formazan 
product that is soluble in culture medium. The quantity of formazan product is related 
to viable cell population. The cells were incubated in a CO2 supplemented incubator for 
1 hour and absorbance was read with a microplate reader (PowerWave, BioTek). The 
490 nm absorbance was obtained and the cytotoxicity was calculated and normalized 
from the absorbance of control samples taken as 100% (cells in identical culture 
environment but with unconditioned medium). 
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Statistical Analysis  
For all experiments, at least 3 disks/IOLs replicate were prepared and analyzed 
independently. The quantified data were subjected to statistical analysis with Prism 
software (GraphPad, San Diego, USA). Unpaired t-test was applied to compare between 
test groups using a 95% confidence interval and two-tailed P value. Not significant (P > 
0.05) is denoted as “ns” and P values smaller than 0.01 and 0.001 are denoted as 2 and 
3 stars, respectively. One-way ANOVA was applied to compare among test groups using 
a 95% confidence interval and Tukey post-test. The error bar of all the graphs presented 
stands for standard deviation.  
 
Results 
Characterization of peptide immobilization by XPS 
XPS was employed to determine the surface chemical composition of HA25 before and 
after RGD peptide immobilization. The XPS spectra of the different statuses of chemical 
modifications were collected and their element compositions were calculated and 
shown in Fig. 4 and Table 2. The peak deconvolution results of the C1s spectra and the 
N1s spectra are shown in Fig. 4A. 
 
LEC adhesion assay 
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The bio-adhesive function of the RGD peptide was evaluated by culturing LECs onto the 
surface-functionalized polymer disks. After fixation and immunofluorescence staining, 
images were taken and the cell coverage ratios were calculated (Fig. 5, 6, and 7). The 
TCPS stands for Tissue Culture PolyStyrene surface optimized for cell culture and serves 
as a reference for LEC proliferation and morphology. As expected, the cells adhered 
least onto the virgin HA25 surface (HA25). As long as RGD peptides were grafted (HA25 - 
RGD Graft), the cell adhesion increased significantly. Moreover, the proliferated LECs 
clustered and spread in a similar fashion on the hydrophobic GF control (Glistening-
Free® (GF) polymer), providing evidence that the surface modification with RGD peptide 
facilitated the morphology maintenance as well as the adhesion of the porcine LECs. 
From this assay, we found that the RGD-grafted sample exhibited higher LEC adhesion 
than the adsorbed sample did (HA25 - RGD Ads) and its coverage ratio was similar to 
that of the hydrophobic material GF (Fig. 5). In addition, enhanced LEC adhesion was 
promoted specifically by RGD peptide grafting and the expression of epithelial 
biomarker cytokeratin remained unaltered (Fig. 6). On the other hand, the RGD grafted 
sample exhibited better LEC morphology maintenance than the starting material HA25 
and showed similar spatial distribution and shape to the hydrophobic material GF (Table 
1 and Fig. 7). 
 
Optical properties 
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The light transmittances of the disks with different peptide surface immobilized statuses 
were measured (Fig. 8). The disks were homogenously transparent with no color 
derivation, and presented a light transmittance of greater than 80% from green light to 
red light spectrum. The RGD-immobilized samples (HA25 – RGD Ads and HA25 – RGD 
Graft) exhibited the same optical properties as the virgin polymer did (HA25). The small 
thickness variance in the polymer disks may cause a homogenous effect in the entire 
transmittance spectrum. The decrease in light transmittance in blue light was a result of 
the “Blue Filtering” design of the bulk polymer disk. 
In addition, from the optical bench measurement on IOLs, both RGD grafted and 
adsorbed samples exhibited no impact on the optical power, expressed in diopters, and 
the contrast sensitivity, expressed by the MTF, of the lenses (Table 3). These parameters 
remained within the pre-established industrial tolerances after IOL modification.  
 
Mechanical properties 
The IOL injection force is the force applied to inject the IOL into the capsular bag from 
the injector. This force may change with a different injector, IOL geometrical design, 
buffer system, material water uptake nature, and surface friction. The higher the 
injection force, the more risk of damage in the IOL (scratches, haptic, or optic cracks) or 
in the injection system (cartridge break). No damage was observed in both the optic and 
haptic part of the IOL and all forces are close to 14 N, which was within the applied 
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industrial criteria for this material and lens model. The test result showed that RGD 
immobilized-IOLs exhibited flexibility compared with the initial lens. 
The haptics are designed to fix the IOL inside the capsular bag and the haptic 
compression force is the force that haptics applies to the capsular bag. Given the 
intrinsic deformability of hydrophobic and hydrophilic acrylic IOL materials, lens haptics 
is compressed in order to compensate capsular bag variations. The test result showed 
that RGD immobilized IOLs exhibited similar compression forces to different test wells 
compared to the initial IOL (statically non-significant by 1-way ANOVA test) (Fig. 9). 
 
Contact angle measurement  
To verify whether the surface functionalization altered the hydrophilicity of the polymer, 
the water contact angles at the surface of the disks were measured after RGD peptide 
grafting. Samples of different RGD-functionalized surface were tested by the water-
droplet method (Fig. 10A). The surfaces were hydrophilic and presented contact angles 
between 61° to 54°. The difference between the contact angles of peptide-adsorbed 
samples and the untreated HA25 disk was not statically significant using ANOVA test, 
indicating that the surface hydrophilicity was approximately the same. The plasma 
treated surfaces, however, became more hydrophilic. In addition, the RGD peptide 
grafted surface became even more hydrophilic than the virgin or plasma treated surface. 
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MTS cytotoxicity assay 
The evaluation of the cytotoxicity of disk-conditioned media on L929 cells was adapted 
from ISO 10993-5 (2009). From Fig. 10B, the viability percentages of all groups were 
above 70%, suggesting that the conditioned media were not cytotoxic. The surface-
functionalized samples created by peptide immobilization did not release active 
substance(s) into the conditioned media. 
 
Discussion 
Strategic selection of bio-adhesive IOL to control PCO 
Surface modification of IOLs to prevent PCO is considered as a simple and safe method 
because it requires no manipulation within the eye and no application of harmful agents 
during IOL implantation[6]. Bio-passive components such as COO-/SO3
- functional groups 
[40] , titanium [41], heparin [42], PFTE/fluorocarbon [43], poly(ethylene-glycol) and its 
derivatives [36,44,45] have been suggested to be generated, grafted, or coated onto the 
IOL materials to reduce cell adhesion or inflammatory reactions [2]. Recently, bio-active 
substances including anti-TGFβ2 antibody [46,47], sulfadiazine (as a mimic of matrix 
metalloproteinases) [48], and 5-ﬂuorouracil (an antimetabolite drug) [49] have been 
proposed to be immobilized onto IOL surfaces to block the processes involved in PCO. 
Despite applied similar surface functionalization technologies, we propose another 
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strategy: the use of RGD peptides to create a bio-adhesive IOL material to aid the tissue 
repair and regenerate the native monolayer structure of LEC. 
The RGD peptide has been suggested to specifically and safely promote cell adhesion. 
First, the RGD sequence is the functional motif of fibronectin [28-30], which is found to 
be adsorbed abundantly onto hydrophobic IOLs. Surface functionalization by RGD 
peptides is a biomimetic strategy to restore the LEC monolayer structure. In addition, 
the RGD modification method has been widely proposed in orthopedics, cancer 
diagnostic and therapy research fields to favor cell adhesion onto material surfaces [50-
64]. Therefore, the fundamental safety profile of the peptide has been constructed from 
basic researches. Moreover, although the RGD-based drug Cilengitide failed in efficacy 
evaluation in Phase III [65], the safety tests of this peptide have already been passed in 
the clinical trial. From the current information, we speculate that the RGD peptide can 
promote LEC adhesion without toxic effects. 
On the other hand, because RGD is recognized by numerous integrins in various cell 
types, different types of cells may non-discriminatorily attach to RGD-functionalized 
surfaces [66]. The lack of biological specificity renders the RGD-based strategies not fully 
optimized for controlling more integrated processes, for example cell differentiation 
[67]. To our knowledge, there is no simple peptide sequence that can specifically attract 
LECs. Therefore, it is possible that macrophages and fibroblastic cells, which migrate 
from uveal tissues into the capsular bag [68], could also attach to the RGD-grafted HA25 
surface as BAB breaks down during the surgery. However, LECs could take advantage of 
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binding to the RGD peptide grafted IOL temporally and spatially. These cells originated 
outside of the capsular bag are found to be maximized inside around 1 to 3 months 
postoperatively [7] whereas literature suggests that cell adhesion promoted by RGD 
becomes irreversible after 24 hours of incubation[69]. The pre-existing LECs, which are 
agitated during cataract surgery, would be the predominant cell type in the capsular bag, 
interacting with the grafted RGD peptide on HA25 polymer and occupying most of the 
available RGD sites on the surface, theoretically. Moreover, BAB alteration can be 
minimized by combining the clear corneal incision surgical method [70], which involves 
an incision in the plane of the cornea without altering uveal tissues [71]. Therefore, the 
risk of adhesion of non-epithelial cell types on RGD functionalized surface can be 
reduced. However, the deduction is based on the in vitro literature and needed to be 
verified by in vivo experimental data. 
The surface functionalization process by plasma treatment and EDC/NHS coupling was 
chosen for its reproducibility and effectiveness. The advantages of applying plasma 
treatment in the surface modification are reliability, reproducibility, relative cost-
effectiveness, and applicability to different sample geometries [72]. In the 
ophthalmological field, the plasma treatment has been shown to be able to graft 
specific molecules to prevent LEC adhesion [41,44]. Nevertheless, the oxidation of 
acrylic IOLs could also control PCO in animal model [73]. In the present case, the 
combination of oxygen and plasma to perform surface functionalization has been 
proposed. Theoretically, oxygen plasma creates more oxygen-containing functional 
groups and transforms hydroxyl groups into carboxylic groups, which are ready for the 
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peptide coupling reaction mediated by EDC and NHS. On the other hand, the EDC/NHS 
coupling method is widely applied in biological research and the detailed reaction 
mechanism is known. The conjugation can be made from the amide bond between the 
amine group of the RGD peptide and the carboxylic acid group of the oxygen plasma 
treated polymer [52,56-61,63,64,74,75]. Therefore, the stepwise process was applied to 
our sample preparation method to graft RGD peptides onto the IOL material surface (Fig. 
3). 
There is another reason to adapt surface functionalization technology in PCO control.  
The surface modification strategy is superior to the pharmaceutical drug loading 
methods in terms of dose control [76]. For the patients applying higher diopter, the IOL 
is thicker and the volume to surface ratio is higher. Therefore, the drug releasing 
kinetics and the overall drug loading dose may vary case by case, and is hard to 
standardize in manufacturing by industry and regulation by government. Therefore, we 
are further convinced that surface functionalization with RGD peptides to create a bio-
adhesive surface is a simple and safe way to control PCO. 
 
RGD peptide-grafted IOL material characterized by XPS 
 XPS analysis was performed to characterize the surface bound status (grafted or 
adsorbed) of the RGD peptides and to verify the effectiveness of the sample preparation 
procedure. Biomimetic grafting was performed by means of a three-step reaction 
procedure: creation of COOH functions onto the HA25 surface using plasma treatment, 
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grafting of the coupling agent, and conjugation of the RGD peptides (Fig. 3). As shown in 
Fig. 3, this grafting method between the polymer surface and RGD or FITC-RGD resulted 
in an amide linkage. 
The theoretical atomic compositions of RGD and FITC-RGD peptides were 56% C, 21% N, 
21% O, 2% S and 64% C, 15% N, 19% O, 2% S, respectively (Fig. 2). On the other hand, 
RGD and FITC-RGD-grafted HA25 surfaces exhibited increased nitrogen element (Table 2) 
in comparison with virgin HA25 and RGD-adsorbed HA25.  
As expected, the amount of nitrogen was higher in the case of FITC-RGD (grafted or 
adsorbed) than in the case of RGD (grafted or adsorbed). Each surface exhibited the 
expected elements with, additionally, a non-negligible pollution of Si, which had no 
impact on components including nitrogen. On the other hand, the virgin HA25 surface 
showed an N pollution (Table 2), which probably originated from additives 
(polymerization initiators or compounds used for blue filtering) [1], impurities, or 
contaminants upon storage and transportation [77].  
The fitting components of C1s spectra and the N1s spectra are shown in Fig. 4A and 4B. 
The C1s components were assigned according to the literature: C-C, 284.9 eV; C-CO + 
amine, 285.8 eV; C-O, 286.6 eV, amide, 287.6 eV; COOR, 288.9 eV [78-80]. As for N1s, 
the assignment was amine, 400 eV; amide 402.5 eV [78,81,82]. 
The peak fitting components of the C1s spectra reflected the increased amide linkage 
between the peptides and the polymer (Fig. 3 and 4). 
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Moreover, the amide/amine increased in the case of HA25 - RGD graft (0.219) in 
comparison with HA25 - RGD ads (0.143) (Fig. 4C). The same statement is also applicable 
in the case of FITC-RGD peptide. The grafted sample exhibited a higher amide/amine 
ratio (0.385) than the adsorbed one (0.345), further illustrating that the conjugation 
occurred between the polymer and the targeting molecules (Fig. 4B, 4C). 
The N1s fitting peak also showed a more defined peak in the case of HA25 - RGD graft 
(in comparison with HA25 - RGD ads) with one amide and one amine component (Fig. 
4A). With FITC-RGD peptides grafted onto HA25, the amide component increased in 
comparison with HA25 - FITC-RGD ads (Fig. 4B). The N1s peak of HA25 FITC-RGD ads was 
well defined considering that the peptide had an additional nitrogen percentage. 
For the RGD and FITC-RGD data set, although the existence of the amide peak (at 402 eV)  
cannot conclude conjugation, we still observed that the amide peak increased in the 
grafted sample (Fig. 4A, 4B), which is also complementary supporting evidence of 
conjugation as we have discussed in C1s fits. By combining C1s and N1s fitting results, 
we conclude that the RGD grafting process was effective to make the RGD surface 
grafted, rather than adsorbed, onto the HA25 polymer. 
 
LEC adhesion enhanced by grafting of peptides and potential of controlling PCO   
Our proposal is to use the RGD peptide to create a bio-adhesive IOL material and to 
examine the LEC response to evaluate the PCO development risk indicators in vitro. 
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Therefore, we used the commercially available hydrophobic IOL material (GF) as a low 
PCO level reference and the starting material, hydrophilic IOL HA25 (virgin polymer), as 
a high PCO level reference. In addition, in order to know the status of normal LECs in 
vitro, tissue culture grade polystyrene (TCPS) was also used for the maximum growth 
control. 
On the other hand, the type of RGD peptide linkage onto the HA25 polymer is important. 
Non-covalent adsorption is sometimes appropriate for drug delivery applications [83]. 
However, in our case, covalent bond formation is more desirable for several advantages 
including higher stability [84], better cell adhesion promoting ability [85], and lower 
potential of uncontrolled desorption of RGD peptides in physiologic environments [86]. 
Therefore, the EDC/NHS coupling step was introduced to ensure the covalent bond 
formation between the RGD peptides and the HA25 polymer. 
The bio-adhesive IOL material made by the grafting of RGD peptides onto the HA25 
surface (HA25 – RGD Graft) promoted LEC adhesion comparable to the level achieved by 
the hydrophobic material (GF). The in vitro LEC adhesion assay of the FITC-RGD-
immobilized surfaces (Fig. 5A) showed that the LEC adhesion was only promoted in FITC-
RGD-grafted sample. The fluorescence backgrounds of the control samples without 
fluorescent peptide treatment (GF, HA25, and HA25 plasma) were significantly lower 
than the samples with fluorescent peptide treatment (FITC-RGD ads and FITC-RGD graft), 
suggesting that fluorescence is an appropriate tool to trace the peptides. The difference 
in fluorescence backgrounds between GF and HA25 may have been a result of the 
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difference in their chemical compositions.  The green fluorescence intensity of the 
sample reflected the amount of the FITC-RGD peptide present. In the case of the RGD-
adsorbed sample, the high fluorescence may have resulted from the sorption 
phenomenon (i.e. molecules penetrated into the inner space of the hydrophilic acrylic 
polymer) [87]. Although the extreme condition of autoclaving had been applied to 
remove the surface-adsorbed peptides, a large amount of FITC-RGD peptides was 
“sorbed” inside the polymer, which could explain the low cell coverage of the FITC-RGD-
adsorbed surface. In addition, RGD-adsorbed surfaces have been reported to have a 
lower ability to promote cell adhesion [85] because of the low stability, unstable links, 
and uncontrolled desorption of biomolecules in physiological environments. 
By image quantification (Fig. 5B), the cell coverage percentage of the FITC-RGD-grafted 
sample (HA25 – RGD Graft) increased to the level observed on the hydrophobic material 
(GF), whereas the plasma treatment (HA25 Plasma) and the adsorbed (HA25 - RGD Ads) 
samples shared the same LEC adhesion level with the virgin polymer (HA25). The same 
observation was also made in the RGD-immobilized surfaces (Fig. 6A). The RGD 
sequence, rather than integrin non-interacting RGE, could promote LEC adhesion, which 
indicates the specificity of the surface functionalization. Therefore, we confirm that the 
LEC adhesion was promoted specifically from the grafting of the RGD sequence. The 
spreading of LECs could be seen only in the RGD-grafted sample and GF sample, 
illustrating the proper adhesion. In contrast, the LECs on the virgin polymer (HA25) or 
plasma-treated (HA25 Plasma) polymer showed a rounded shape, suggesting loose 
adhesion. In addition, the similarity of LEC coverage level between the RGD-grafted 
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hydrophilic material (HA25 – RGD Graft) and the hydrophobic material (GF) (Fig. 6B) 
would imply similar capsule-IOL adhesive interaction mediated by LECs, and therefore 
similar low incidences of PCO.  
The bio-adhesive RGD-grafted HA25 material shared similar EMT marker expression to 
the hydrophobic material level as well. After cataract surgery, the remaining LECs 
undergo EMT and express different proteins during PCO formation [88]. The progression 
of EMT can be detected with these protein biomarkers. For example, α-SMA is an 
acquired marker and cytokeratin is an attenuated marker during EMT [88]. The 
background expression of α-SMA is observed in porcine LECs as reported in other 
mammals [89]. Comparing with the hydrophobic sample or the TCPS sample, the LECs 
on the RGD-grafted hydrophilic sample do not acquire more α-SMA (Fig. 5A). On the 
other hand, the expression of cytokeratin was not attenuated in the RGD-grafted 
sample compared with the controls (Fig. 6B). Therefore, the biomarker assays of EMT 
illustrated no difference between the RGD-grafted hydrophilic material and the 
hydrophobic material, which would imply a low chance of undergoing EMT and induce 
PCO. 
In addition, the epithelium morphology evidence showed that the bio-adhesive IOL 
material did not promote EMT. The native EMT status of LECs is cuboid-like with evident 
cell-cell adhesions [90]. Cultured in vitro or stimulated by TGF-β, the LECs disintegrate 
from the clustered structure and become fibroblastoid spindle-shaped cells. From the 
literature, the compound rapamycin is suggested to prevent PCO by inhibiting EMT 
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[91,92]. Therefore, the porcine TGF-β and rapamycin-treated LECs on the TCPS surface 
could be used in our experiment as the PCO-positive and PCO-negative controls, 
respectively (Fig. 7). Although the porcine LECs used in this assay were naturally spindle-
shaped [93], the LECs on RGD-grafted surface were not further elongated compared to 
those on the TCPS sample. In addition, the LEC spatial distributions and the 
morphologies were similar between the RGD-grafted and GF samples, implying a low 
potential to undergo EMT and induce PCO. 
The relationship between RGD peptides and EMT remains unclear from the literature. 
For the epithelium interacting with soluble RGD peptides in the perspective of EMT, 
contradictory results have been reported. One study suggested that EMT is favored by 
finding that TGF-β1 activated proteolysis of the L1 cell adhesion molecule (L1CAM) 
induced its RGD-motif binding to integrin and triggering the EMT pathways [94]. 
However, in another report, blockage of integrin by soluble RGD peptides inhibited the 
human hepatic epithelial carcinoma from acquiring a mesenchymal phenotype and 
protein marker vimentin, in a system of co-culture with mesenchymal stem cells [95]. In 
addition, studies on associating EMT with the integrin expression level of LEC are 
controversial [96,97]. Furthermore, the soluble RGD peptides did not interfere with the 
avian LECs undergoing EMT in an ex vivo assay [97]. In contrary, the soluble RGD 
peptides blocked the TGF-β1-induced EMT in mouse mammary gland cells [98]. As for 
the grafted RGD peptides, there has been no precedent to predict the EMT effect. 
Therefore, direct assessment of EMT of the LEC response to grafted RGD peptides is 
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needed, and our preliminary experimental results showed no significant changes in 
biomarker expression and morphology, at least under our experimental conditions. 
 
Immobilization of peptide not altering its functions required for IOL implantation 
As a candidate of a new biomaterial in ophthalmic implant, the peptide-immobilized 
polymer should possess appropriate optical properties, mechanical properties, and 
biocompatibility. Since the starting material, HA25, is a conventional biomaterial used in 
IOLs, it is appropriate to use it as a control to investigate the impact of the peptide 
surface functionalization process. 
Surface modification on IOLs by ion beam or plasma methods has been proposed to 
improve the surface hydrophilicity or biocompatibility [42,99]. However, it is still risky to 
have color deviation after coating [41]. In our case, the grafting of RGD peptides onto 
the IOL surface did not change the light transmittance spectrum partially or globally (Fig. 
8), illustrating no color deviation and high transparency as the starting material. The 
transmission spectrum in the 550 nm to 999 nm was greater than 90%, which is similar 
to the literature [46]. The transmittance drop in the range between 350 nm and 550 nm 
was due to the presence of “blue filtering” chromophore copolymerized within the IOL 
material aiming to prevent the retina from the toxic blue light. In addition, UV-light filter 
is also typically copolymerized to filter the light up to 350 nm. The present data 
demonstrated that the surface functionalization procedure of plasma treatment and 
RGD peptide grafting did not change the light transmittance of the bulk material. 
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An intraocular lens is intended to restore the vision of the patient, and its optical 
parameters such as diopter are calculated prior to implantation. Therefore, any kind of 
surface modification in the lens should not be detrimental for its optical performance. 
The optical power of an IOL is expressed in diopters and the industrial tolerances, 
inspired by the ISO 11979-2, should be respected. The data from the optical bench 
measurement demonstrated that the experimental optical power of the neat and 
modified lenses was preserved and remained within the tolerances (Dexperimental = 
Dtheoretical ± 0.34D), suggesting no IOL curvature or refractive power deviation as a result 
of the modification.  
Indirectly, the preservation of the contrast sensitivity of the optic, expressed by the MTF, 
argues for good surface quality, i.e. homogeneous, low roughness, the latter parameters 
being most frequently associated with contrast sensitivity deviations [100]. 
Although plasma treatment and surface coating have been applied to improve surface 
function in biomaterial studies, there are still evidences showing that these 
modifications may alter the mechanical properties of the bulk media [101,102]. As for 
the IOL study, this aspect becomes important because changes in mechanical properties 
may lead to implantation failure during (failure of injection system, unfolding) or after 
cataract surgery (dislocation of IOL, damage of IOL or lens capsule). Therefore, the 
mechanical properties tests were aimed at verifying whether the RGD-grafted IOL is still 
suitable for ophthalmological implantation. The measurement of IOL injection forces is a 
part of the standardized testing to ensure the safety of the device during the 
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implantation. From our data, the injection forces of the test groups were close to 14 N, 
falling into the normal range of the hydrophilic IOL [39] . 
The measurement of haptic compression is also a part of the standardized testing of IOL 
performance to simulate its behavior in vivo. The haptic compression force should 
neither be too high to damage the capsule bag nor too low to unfix the IOL. Reports 
have shown that the maximum force loading of lens capsule is between 400 to 800 mg, 
compared with 23 to 131 mg in our RGD-grafted IOL [103]. This low force range ensures 
the mechanical safety of the lens capsule. Additionally, the haptics should exert a steady 
force to different sizes of capsular bags for different patients. The forces of the RGD-
immobilized IOLs exhibited stability as the virgin IOL, illustrating appropriate mechanical 
properties. On the other hand, striae formation (caused by high extension forces) in the 
posterior capsular after surgery may provide a chance for LEC migration and lead to PCO 
formation. The lower compression force may lead to lower circumferential pressure on 
the posterior capsule, which minimized the striae formation. The observed forces in our 
RGD-immobilized IOLs were close to those in the virgin IOL models. 
Non-cytotoxicity is a general biocompatibility requirement for all medical implants. The 
MTS assay is widely applied to evaluate the cell viability by relating the intracellular 
dehydrogenase activity to the living cell population [104,105]. The use of L929 to 
determine the cytotoxicity of medical devices following ISO 10993-5 is also applied in 
biomaterial researches on IOLs and other medical devices [99,104,105]. The use of the 
L929 cell line is preferred because it is established and obtained from recognized 
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repositories (ISO 10993-5.5). In our case, since the virgin polymer itself did not attract 
cells, it would lead to a low viability value although it was proven to be non-cytotoxic. 
Alternatively, indirect cytocompatibility study is suggested in ISO 10993-5:2009 by using 
conditioned medium to detect the release of toxic substances. Our data revealed that 
the RGD peptide-immobilized samples had cell viability values greater than 70%, 
indicating no cytotoxic potential by the ISO definition. In addition, the values were also 
comparable to those of the virgin polymer, which was proven to be non-toxic in clinical 
cases. 
It is known that the surface hydrophilicity could affect cell adhesion behavior. If the 
surface is extremely hydrophobic, the adsorbed proteins will be denatured [106]. The 
receptors on the cellular membrane can hardly recognize the denatured proteins and 
thus, no cell can adhere. On the other hand, if the surface is extremely hydrophilic, no 
protein could be adsorbed, which leads again to no cell adhesion. Previous studies have 
shown that the optimized hydrophilicity for cell adhesion is in the range of 45° to 75° of 
aqueous contact angle [1,106]. From our result (Fig. 10A), all the samples were located 
in the optimized range. The RGD and FITC-RGD peptide-adsorbed samples showed 
similar contact angles to those exhibited by the HA25 control sample, suggesting that 
the surface-adsorbed peptides were mostly removed during the wash process and had 
no effect on the contact angle. In addition, the oxygen plasma-treated samples became 
significantly more hydrophilic, which corresponds to the literature [80]. The 
phenomenon of RGD-grafted surfaces exhibiting even lower contact angles could be 
explained by the “Hydrophobic Recovery” effect of the material and hydrophilicity 
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nature of the RGD peptide. Plasma-treated materials have been reported to have a 
“Hydrophobic Recovery” effect which a polymer partially restores the original 
hydrophobic surface to the extent that it adapts its composition to the interfacial force 
[80]. The mechanism of this effect is considered as the reorientation of the non-polar 
groups from the bulk to the surface or reorientation of polar groups from the surface to 
the bulk phase [107]. Since the grafting reaction conjugates peptides to the carboxyl 
group at the surface, the volume of the peptide would inhibit the reorientation of the 
carboxyl group into the bulk. In addition, the outer space occupied by the peptide may 
also be a hindrance to inhibit the reorientation of non-polar groups from the bulk to the 
surface. Overall, the grafting of peptides may lead to a reduced hydrophobic recovery 
effect [108]. On the other hand, the RGD peptide is mainly composed of hydrophilic 
amino acid residues. The FITC-RGD peptide-grafted surfaces, however, showed higher 
contact angles than the RGD-grafted surfaces and exhibited no significant difference 
compared to the plasma-treated surfaces, presumably because of the relative 
hydrophobic fluorescein moiety of the FITC-RGD peptide (Fig. 2). Therefore, RGD-
grafted surfaces are more hydrophilic than plasma-treated or untreated HA25 surfaces 
with small contact angle differences.  
In addition, the RGD peptides did not lose bioactivity even after multiple autoclaves. The 
wash step adapted 10 cycles of autoclaving providing an opportunity to examine not 
only the stability of the biological function of the peptide but also the robustness of the 
peptide-functionalized surface in harsh conditions. During the consecutive autoclaving 
process, the extraction of the FITC-RGD peptides occurred between the polymer and the 
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deionized water. The peptide concentrations of the eluates were calculated by 
measuring the fluorescence. The concentration of the first few eluates may vary from 
different samples, but the last eluate showed as low as smaller than 10 µM in 
concentration (Fig. S2). This observation indicated the wash step removed most 
physically adsorbed RGD peptides and the potential free peptides dissociated in the 
physiological environment were too few to induce any adverse effect in the body, 
although the RGD peptide-based compound seems lack the maximum tolerated dose, as 
well as significant attributable toxicity [109]. Therefore, with the critical washing step, 
we control the bio-adhesive IOL surface without the risk of high concentration of RGD 
peptide released into the body’s circulation. 
 
Conclusions  
PCO has become a public health issue because of the rising incidence of age-related 
cataract and accompanied increase in IOL implantation. Ophthalmologists are awaiting a 
solution to prevent PCO. We propose a potential solution by functionalizing the surface 
of a conventional hydrophilic acrylic IOL material with the RGD peptide sequence to 
promote LEC adhesion. This strategy aims at recovering the synthetic intraocular lens to 
mimic the natural environment. 
The surface functionalization process was accomplished by oxygen plasma treatment 
followed by conjugation, and the washing procedure consisted of consecutive water 
extraction in autoclave temperature. This new biomaterial exhibited similar LEC 
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adhesion and morphology as well as EMT biomarker expression profiles compared to 
the hydrophobic material. The modification did not impede other properties (optical, 
mechanical, and cytotoxicity) required for an ophthalmic implant material. 
Our pioneering in vitro study of the bio-mimicking strategy suggests that the LEC 
adhesion is promoted and this surface-functionalized IOL material exhibits no 
detectable effect toward EMT, which is the molecular cell biology mechanism of PCO. 
This hypothesis still needs to be examined by in vivo assays to validate the effectiveness 
of PCO prevention. 
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Figure Legends 
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Fig. 1 Fabrication and chemical structure of virgin HA25 material  
 
Fig. 2 Chemical structure of RGD, RGE, FITC-RGD  
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Fig. 3 Chemical structure and reaction to prepare RGD surface-functionalized HA25 disk / IOL 
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Fig. 4 XPS analysis of peptides immobilized onto HA25 
(A) XPS C1s (left) and N1s (right) spectra of the HA25 - RGD grafted (upper) and adsorbed (lower) 
sample.  
(B) XPS C1s (left) and N1s (right) spectra of the HA25 - FITC-RGD grafted (upper) and adsorbed 
(lower) sample.  
 (C) From C1s spectra in (A) and (B), quantification of amide/C-C and (amine + C-CO)/C-C ratios 
for each material 
 
Fig. 5 LEC adhesion assays of the polymer disks immobilized with FITC-RGD 
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(A) Fluorescence microscopy images in green channel (detecting FITC-RGD) and red channel 
(detecting α-SMA) (bar = 100 µm) 
(B) Quantification of the cell coverage ratio (red channel) and the average fluorescence intensity 
(green channel) from three independent images shown in (A) 
 
Fig. 6 LEC adhesion assay of the polymer disks immobilized with RGD or RGE.  
(A) The fluorescence images of LEC-adhered surface (cytokeratin in red, tubulin in green, 
nucleus in blue) (bar = 100 µm) 
(B) Quantification of the cell coverage ratio (green channel) (left) and the normalized EMT 
marker expression profile (red channel / green channel) (right) from three independent images 
shown in (A) 
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Fig. 7 LECs adhesion on RGD grafted disk in contrast with EMT inhibitor (Rapamycin) or 
promoter (TGF-β) treated cells on TCPS. (α-SMA stained in red, tubulin in green, nucleus in blue) 
(bar = 100 µm) 
 
Fig. 8 Light transmittance spectra of the neat and modified disks (No significant difference 
among 3 groups by ANOVA) 
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Fig. 9 Haptic compression forces of IOLs collected for various simulated capsular bags sizes 
 
Fig. 10 The water contact angle (A) and the cytotoxicity potential (B) of the neat and modified 
disks 
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Fig. S1 Illustration of plasma, peptide-adsorbed, and peptide-graft samples from neat HA25 
material 
 
Fig. S2 Peptide concentrations of autoclave eluates of the FITC-RGD-immobilized disks 
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Tables 
Table 1 Nomenclature of samples used in this study 
Name Oxygen 
Plasma 
treatment 
Peptide 
Incubation 
Description 
TCPS N/A N Tissue culture polystyrene, used as 
normal LEC morphology / proliferation 
control 
TCPS/TGF-β N/A N LEC cultured onto TCPS with additional 
TGF-β (20 ng/µL) in normal culture 
medium, used as EMT positive control 
TCPS/Rapamycin N/A N LEC cultured onto TCPS with additional 
rapamycin (20 nM) in normal culture 
medium, used as EMT negative control 
GF N N Hydrophobic acrylic polymer Glistening-
Free, used as PCO negative control 
HA25 N N Hydrophilic acrylic polymer water-uptake 
25%, used as PCO positive control 
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HA25 plasma Y N HA25 treated with oxygen plasma, used 
for plasma effect evaluation 
HA25-RGD ads N Y (RGD) RGD adsorbed onto HA25, used for 
adsorption effect evaluation 
HA25-RGD graft Y Y (RGD) RGD grafted onto HA25, used for LEC 
adhesion promotion 
HA25-RGE ads N Y (RGE) RGE adsorbed onto HA25, used for 
adsorption effect evaluation 
HA25-RGE graft Y Y (RGE) RGE grafted onto HA25, used for a 
negative control of LEC adhesion 
promotion 
HA25-FITC RGD 
ads 
N Y (FITC-RGD) FITC-RGD adsorbed onto HA25, used for 
adsorption effect evaluation by 
fluorescence tracing 
HA25-FITC RGD 
graft 
Y Y (FITC-RGD) FITC-RGD grafted onto HA25, used for LEC 
adhesion promotion and fluorescence 
tracing 
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Table 2 Experimental atomic composition obtained by XPS analysis 
Atomic % C% O% N% Si% 
HA25 70.8 25.2 0.4 3.6 
HA25 - RGD ads 70.7 25.9 0.2 3.2 
HA25 - RGD graft 70.0 26.2 1.0 2.8 
HA25 - FITC-RGD ads 69.1 24.3 2.4 3.7 
HA25 - FITC-RGD graft 70.0 23.5 3.1 3.0 
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Table 3 Neat and modified IOLs analyzed with an optical bench 
Sample name MTF  Theoretical 
diopter, D 
Measured diopter, 
D 
HA25 n° 1 0.64 20,50 20.35 
HA25 n° 2 0.65 20,50 20.78 
HA25 n° 3 0.65 21,00 21.08 
HA25 - RGD ads n°1 0.60 22,50 22.71 
HA25 - RGD ads n°2 0.65 22,50 22.23 
HA25 - RGD ads n°3 0.63 18,50 18.38 
HA25 - RGD graft n°1 0.65 22,50 22.62 
HA25 - RGD graft n°2 0.61 15,50 15.57 
HA25 - RGD graft n°3 0.65 21,00 21.10 
Acceptable tolerances: MTF > 0,43; diopter theoretical ± 0,34D 
 
